mannitol has been researched along with Bone Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Dong, G; Liu, R; Sheng, Q; Tong, X; Zhao, Y | 1 |
Cai, W; Gao, YJ; Li, PW; Liu, B; Mao, GG; Wang, SJ; Zhang, G; Zhang, Y; Zhou, YF | 1 |
Bernard-Well, E; Sebaoun, J | 1 |
Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D | 1 |
1 trial(s) available for mannitol and Bone Cancer
Article | Year |
---|---|
[Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy].
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Male; Mannitol; Middle Aged; Pain, Intractable; Pamidronate; Prospective Studies; Zoledronic Acid | 2005 |
3 other study(ies) available for mannitol and Bone Cancer
Article | Year |
---|---|
Delayed pneumocephalus induced by repeated percutaneous aspiration after spinal surgery: A case report and literature review.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Decompression, Surgical; Diuretics, Osmotic; Drainage; Humans; Liver Neoplasms; Male; Mannitol; Middle Aged; Neoplasm Staging; Neuroimaging; Orthopedic Procedures; Pneumocephalus; Postoperative Complications; Reoperation; Thoracic Vertebrae; Treatment Outcome | 2021 |
[At the borderline of the Schwartz-Bartter syndrome. Antidiuresis after water and mannitol loading in 10 cases of cancer of the breast without hyponatremia].
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Diuresis; Female; Humans; Mannitol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Vasopressins; Water | 1967 |
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neoplasms; Calcium; Capsules; Carcinoma 256, Walker; Cell Line; Diphosphonates; Diuretics, Osmotic; Durapatite; Injections, Intravenous; Intestinal Absorption; Macrophages; Male; Mannitol; Osteogenesis; Pamidronate; Rats; Rats, Inbred Strains; Tight Junctions; Tissue Distribution | 1999 |